about
Localization of BRCA1 protein in breast cancer tissue and cell lines with mutationsEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerp53 acetylation is crucial for its transcription-independent proapoptotic functionsBRCA1 regulates p53-dependent gene expressionTGF beta1 and PDGF AA override collagen type I inhibition of proliferation in human liver connective tissue cellsNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskA guide for functional analysis of BRCA1 variants of uncertain significanceEnhancer scanning to locate regulatory regions in genomic lociPathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approachGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesFunctional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibilityFunctional impact of missense variants in BRCA1 predicted by supervised learningProbing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSBRCT domains: A little more than kin, and less than kindInvolvement of the SH3 domain in Ca2+-mediated regulation of Src family kinases.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.Long-term culture of cholangiocytes from liver fibro-granulomatous lesionsBRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines.Functional annotation signatures of disease susceptibility loci improve SNP association analysis.Charting the landscape of tandem BRCT domain-mediated protein interactions.A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.Phosphatases in the cellular response to DNA damage.Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair.Functional and structural analysis of C-terminal BRCA1 missense variants.Differences in BRCA counseling and testing practices based on ordering provider type.Brain tumor risk according to germ-line variation in the MLLT10 locus.Tandem BRCT Domains: DNA's Praetorian Guard.LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.BRCA1: the enigma of tissue-specific tumor development.BRCA1 Circos: a visualisation resource for functional analysis of missense variants.Absence of constitutional H2AX gene mutations in 101 hereditary breast cancer families.Yeast two-hybrid junk sequences contain selected linear motifsClassification of BRCA1 missense variants of unknown clinical significance.Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
P50
Q24308016-C088FE5C-1A42-4EA7-A740-9841EBB6508BQ24633316-BA50289F-F368-4EC5-8271-C0D57ABC76A6Q24657909-E97F402A-117C-47AC-8756-C68C003C703DQ24685083-7E836AEC-0779-41A7-8BBF-5682B93E68A3Q24809810-7428B726-4097-4079-9A15-2F7A0F9C50A5Q26799669-50F266FE-FD81-4159-A192-F0DFD1733320Q26829268-3B3DB96C-34F8-473C-ADDC-35F1570590C1Q27310315-BE94E20C-721B-44A4-BB08-D09596451035Q27649882-698014B4-1C7F-4739-A957-2EA0FECFD0A3Q28388497-4A1BAFB0-4851-48BF-9F5B-A490CCE30619Q28394851-B70CA5E1-61FD-4391-B016-7B36C05DBBBCQ28469139-53887060-E984-459E-BFBE-501D238C93A4Q28539000-52352B97-CADB-4030-9CEB-AF17C1689B5BQ28584533-90327493-2299-4F10-829F-93632B13BE30Q28728558-2DEA01C9-4085-4B0C-9EA9-8C11E1AF3EA4Q30159867-908D3F88-6DC4-49AA-A157-09EADD89FA16Q30252854-E1984AE8-18B5-40BD-8221-09833A0DA0EFQ30275132-09A0FD0E-3F04-4DB6-B1D3-1D1CC17A06BAQ30278587-20EC5671-9857-4AF9-A6A7-668AE380ED0BQ33238504-581EA19C-3D37-4A66-BF00-8C9757160F78Q33523959-C3F09912-34E7-48C3-881F-90A7226FB016Q33701048-80A40B1D-EF83-4976-A592-97E8F29E26C3Q33782757-AF59D34C-6AFA-4E72-8391-91F3AA440BD6Q33857421-478EC5DA-E34E-4644-BD14-A87E1319ED20Q33910123-7E2148B6-0EA0-477C-8D54-9EF9245C0224Q34116553-6FC6A637-877D-448F-A73F-2BD820903FE9Q34198570-1BA98697-E689-4647-BC68-8E97462D7603Q34581303-4FAF5645-0056-4767-9BB8-CF6F8096707CQ34581343-4F4A09CD-2D04-4471-9413-A8BC5B91FE09Q34684253-B6638A05-2A2F-44CB-95D1-5DB9204222AEQ34691719-2723BF4C-69F1-4980-86C8-0AC8F3D25F30Q34705193-D4002A6D-3291-4E18-B7AD-74E3B5F435D8Q34865929-F16BBB96-3BB5-4107-8B35-7EA0D1C8B065Q35022313-B2ABDF48-BAD2-4537-A147-44EE2A8E6155Q35152213-3C6036C4-8688-4FD6-A386-48DD8FD4AD47Q35152213-59B12808-E174-4743-8B4F-F7E8216574B6Q35350825-6434E649-05E7-4A6A-82B5-5C0D509435FAQ35442002-E2045E9A-C36E-4732-B6AB-77F142ECE564Q35447701-207DC08B-A0DE-4E29-9E84-4162C269C80EQ35447780-EED5A392-1016-426F-AC8C-BC3C67D746FB
P50
description
researcher ORCID ID = 0000-0002-8448-4801
@en
wetenschapper
@nl
name
Alvaro Monteiro
@ast
Alvaro Monteiro
@en
Alvaro Monteiro
@es
Alvaro Monteiro
@nl
type
label
Alvaro Monteiro
@ast
Alvaro Monteiro
@en
Alvaro Monteiro
@es
Alvaro Monteiro
@nl
altLabel
Alvaro N A Monteiro
@en
Monteiro AA
@en
prefLabel
Alvaro Monteiro
@ast
Alvaro Monteiro
@en
Alvaro Monteiro
@es
Alvaro Monteiro
@nl
P106
P1153
7102146021
P21
P2798
P31
P496
0000-0002-8448-4801